Exercise & Autoimmune
topic
Regular moderate exercise is associated with reduced autoimmune disease risk and symptom improvement in established autoimmune conditions including rheumatoid arthritis, multiple sclerosis, lupus, inflammatory bowel disease, and type 1 diabetes — through mechanisms including anti-inflammatory myokine production, regulatory T-cell expansion (promoting immune tolerance), reduced systemic inflammation, and gut microbiome modulation that improves intestinal permeability and reduces the systemic immune activation that drives autoimmune pathology.
Role
Exercise for autoimmune conditions is the therapeutic application most inconsistently implemented in clinical autoimmune management — with both patients and clinicians frequently avoiding exercise during disease flares (sometimes appropriate) while neglecting exercise during remission (consistently beneficial). The evidence that moderate regular exercise in autoimmune conditions reduces inflammatory markers, improves functional capacity, and in some conditions reduces disease activity scores is robust enough that exercise should be a standard rather than optional component of autoimmune management — yet most autoimmune treatment protocols focus entirely on immunosuppressive medications without a systematic exercise prescription component.